人類生殖技術(Human Reproductive Technologies)：製品、市場、參與企業 -2005年版-

Human Reproductive Technologies: Products, Markets and Manufacturers

出版商	BCC Research
出版日期	2005年02月	商品編碼	26653
內容資訊	英文 176 Pages
價格	本報告書已不再販售

簡介
目錄
相關商品

本報告已在2011年07月19日停止出版。

簡介

人類生殖技術/製品的美國整體市場獲利在2004年已經創下約65億美金的紀錄，一般預料之後也會以每年8.6％的速度成長，在2009年達到98億美金的市場規模。

在調查尖端技術市場上，擁有不錯業績的市調公司Business Communications Co., Inc.(總公司：康乃狄克州)，詳盡地調查與分析人類生殖技術/製品的美國市場，並出版綜合報告書 "Human Reproductive Technologies: Products, Markets and Manufacturers" 。

此報告書使用包括57張圖表在內的176頁篇幅，不僅重新評估男女性的生殖醫療，並說明標準的治療藥/裝置/技術的概要、不孕症/生殖補助醫療技術/不孕症診斷/避孕/性功能障礙等領域的市場規模；也探討至2009年前的未來預測、市場參與企業與現有競爭者的市場佔有狀況、製品與技術的通路分析等。此報告書的概略架構如下所示。

說明

產業概要

生殖系統構造與功能
- 男性
- 女性
- 性反應期
- 男性/女性生殖系統的神經賀爾蒙控制
- 高齡影響
生殖醫療問題與傾向
- 避孕保險
- 法律處置
- 避孕藥的新使用方式
- 高齡與不孕症
- 避孕貼所導致的死亡
- 性功能障礙與癌症
- 不孕症與癌症
- 行銷策略
- 針對女性的宣傳手法
- 偽造製品
- 未註冊商品的加入
- 國際問題
- 剩餘胚胎與胎兒
- 設計嬰兒
- 幹細胞與其他爭議
- 引起爭論的胚胎處理
人口統計

不孕症市場

不孕症的解說與概要
- 定義
- 病因
- 發生率與罹患率
- 評價
- 原因不明的不孕症
- 多胎
治療方法
- 不孕治療藥
- 人工生殖技術
- 診斷
整體市場獲利與未來預測

避孕市場

避孕解說與概要
治療方法
- 治療藥
- 裝置
未來發展
整體市場獲利與未來預測

性功能障礙市場

解說與概要
- 種類
- 原因
- 人口統計
治療方法
- 治療藥
- 裝置
未來發展
整體市場獲利與未來預測

專利

各參與企業的專利分析
各適應症專利
- 不孕症治療
- 避孕
- 性功能障礙
主要參與企業

整體市場

各範疇整體市場規模
各範疇產業參與企業
各製品種類整體市場規模

附錄

美國主要不孕治療院名單
企業檔案
企業名單

In each of the three major areas of infertility, contraception and sexual dysfunction, there is increasing interest and advancements. One of the most widely publicized, celebrated and, at the time, controversial medical landmarks in this area was the use of assisted reproductive technology (ART) to manage infertility. Recent developments in the field of ART have intensified the hopes and wishes of infertile people to resolve their infertility.

New developments in the area of contraception have stepped up the quest for easier, safer and more convenient contraception methods. There is no miracle drug or contraception method but scientists are pursuing several avenues of discovery to create better options for individuals.

Sexual dysfunction now is an acknowledged disorder in the eyes of the general public and the medical community. Prior to the introduction of Viagra, the disorder was present but not acknowledged, and largely went untreated.

This BCC study presents a comprehensive, up-to-date look at the market for reproductive drugs and technologies. Markets are divided according to treatment type and indication. The products in some markets are mature, while those in other markets are just beginning to emerge. The competitive landscape is comprised of large, established pharmaceutical companies and many smaller developing companies. The reproductive health arena still is wide open in terms of competition because there still is a great need to provide products that are safe and effective.

SCOPE OF STUDY

The report contains:

A review of male and female reproductive health
An overview of standard pharmaceutical treatments, devices and technologies
An analysis of market size in the categories of infertility, artificial reproductive technologies, fertility diagnostics, contraception and sexual dysfunction with forecasts to 2009
Market participants and current competitor market shares
An investigation of pipeline products and technologies.

INTRODUCTION
SUMMARY
- Summary Table: TOTAL REVENUES OF U.S. REPRODUCTIVE TECHNOLOGIES AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
- Summary Figure: TOTAL REVENUES OF U.S. REPRODUCTIVE TECHNOLOGIES AT U.S. MANUFACTURERS SALES LEVELS, 2002-2009 ($ MILLIONS)
INDUSTRY OVERVIEW
- Table 1 STRUCTURAL HOMOLOGUES OF THE MALE AND FEMALE REPRODUCTIVE SYSTEMS
  - ISSUES AND TRENDS OF REPRODUCTIVE HEALTH
    - CONTRACEPTIVE INSURANCE
    - LEGISLATIVE ACTIONS
      - Bioethics Commission
        
        Bioethics Commission (Continued)
    - NEW USE FOR CONTRACEPTIVES
      - New Use for Contraceptives (Continued)
    - AGING AND INFERTILITY
    - DEATH BY CONTRACEPTIVE PATCH
    - SEXUAL DYSFUNCTION AND CANCER
    - INFERTILITY AND CANCER
      - Chemotherapy
      - Radiation
      - Prevention Strategies
      - Procreative Alternatives
        
        Procreative Alternatives (Continued)
    - MARKETING TACTICS
    - MERCHANDIZING TARGETING WOMEN
    - COUNTERFEIT PRODUCTS
    - GENERIC PARTICIPATION
- Table 2 PRESCRIPTION GENERIC DRUG APPROVALS BY COMPANY AND APPROVAL DATE 2003-2004
  - DEMOGRAPHICS
- Table 3 U.S. LIVE BIRTH RATES, 1960-2004 (THOUSANDS)
- Figure 1 U.S. LIVE BIRTH RATES, 1960-2004 (THOUSANDS)
- Table 4 U.S. POPULATION BY SELECTED AGE GROUPS AND BY PERCENT OF TOTAL POPULATION, 2003-2030 (THOUSANDS)
- Figure 2 U.S. POPULATION SELECTED AGE GROUPS BY PERCENT OF TOTAL POPULATION, 2003-2030
- Table 5 CHARACTERISTICS OF WOMEN WHO HAVE HAD A CHILD IN THE LAST YEAR: 2000 AND ESTIMATED 2005
- Table 6 WOMEN WHO HAVE HAD A CHILD IN THE LAST YEAR BY AGE AND LABOR FORCE STATUS: 1980 TO 2000
- Table 7 ESTIMATED CONTRACEPTIVE USE BY TYPE BY AGE, ETHNIC GROUP AND MARITAL STATUS (%)
INFERTILITY MARKET
- Table 8 PRESCRIPTION FERTILITY DRUGS
- Table 9 MARKET SIZE OF U.S. INFERTILITY PHARMACEUTICALS AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
- Table 10 INFERTILITY PHARMACEUTICAL MANUFACTURER MARKET SHARE BY REVENUES, 2004 ($ MILLIONS)
- Figure 3 INFERTILITY PHARMACEUTICAL MANUFACTURER MARKET SHARE BY REVENUES, 2004 (%)
- Table 11 INFERTILITY DRUGS IN DEVELOPMENT
- Table 12 2001 NATIONAL SUMMARY OF ARTIFICIAL REPRODUCTIVE THERAPIES
- Table 13 2001 NATIONAL ARTIFICIAL REPRODUCTIVE THERAPIES CYCLE PROFILE
- Table 14 2001 PREGNANCY SUCCESS RATES
- Table 15 MARKET SIZE OF U.S. ARTIFICIAL REPRODUCTIVE TECHNOLOGIES AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
- Table 16 MARKET SIZE OF U.S. FERTILITY DIAGNOSTICS AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
- Table 17 FERTILITY DIAGNOSTIC MANUFACTURER MARKET SHARE BY REVENUES, 2004 ($ MILLIONS)
- Figure 4 FERTILITY DIAGNOSTIC MANUFACTURER MARKET SHARE BY REVENUES, 2004 (%)
  - TOTAL INFERTILITY MARKET REVENUES AND FORECAST
- Table 18 MARKET SIZE OF U.S. INFERTILITY TREATMENTS AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
- Figure 5 MARKET SIZE OF U.S. INFERTILITY TREATMENTS AT U.S. MANUFACTURERS SALES LEVELS, 2002-2009 ($ MILLIONS)
CONTRACEPTION MARKET
- Table 19 CONTRACEPTIVE EFFECTIVENESS: THEORETICAL AND ACTUAL USE RATES
  - METHODS OF TREATMENT
    - PHARMACEUTICALS
      - Types
        
        Oral Contraceptives
        
        Oral Contraceptives (continued)
        Oral Contraceptives (continued)
        Oral Contraceptives (continued)
- Table 20 MOST COMMONLY USED ORAL CONTRACEPTIVES, 2004
- Table 21 ESTROGEN AND PROGESTIN HORMONE DOSES IN COMBINED BIRTH CONTROL PILLS
- Table 21 (CONTINUED)
- Table 22 PROGESTIN POTENCY OF DIFFERENT ORAL CONTRACEPTIVE PROGESTINS
- Table 23 CURRENT PILL PROBLEMS AND CHOICE OF PILL TO SWITCH TO
- Table 24 MARKET SIZE OF U.S. CONTRACEPTIVE PHARMACEUTICALS AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
- Table 25 CONTRACEPTION PHARMACEUTICAL MANUFACTURER MARKET SHARE BY REVENUES, 2004 ($ Millions)
- Figure 6 CONTRACEPTION PHARMACEUTICAL MANUFACTURER MARKET SHARE BY REVENUES, 2004 (%)
- Table 26 MARKET SIZE OF U.S. CONTRACEPTIVE DEVICES AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
- Table 27 CONTRACEPTIVE DEVICE MANUFACTURER MARKET SHARE BY REVENUES, 2004 ($ MILLIONS)
- Figure 7 CONTRACEPTIVE DEVICE MANUFACTURER MARKET SHARE BY REVENUES, 2004 (%)
  - FUTURE ADVANCEMENTS IN CONTRACEPTION
- Table 28 CONTRACEPTIVE DRUGS IN DEVELOPMENT
- Table 28 (CONTINUED)
  - TOTAL MARKET REVENUES AND FORECAST
- Table 29 MARKET SIZE OF U.S. CONTRACEPTIVE PRODUCTS AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
- Figure 8 MARKET SIZE OF U.S. CONTRACEPTIVE PRODUCTS AT U.S. MANUFACTURERS SALES LEVELS, 2002-2009 ($ MILLIONS)
SEXUAL DYSFUNCTION MARKET
- Table 30 MARKET SIZE OF U.S. SEXUAL DYSFUNCTION PHARMACEUTICALS AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
- Table 31 SEXUAL DYSFUNCTION PHARMACEUTICAL MANUFACTURER MARKET SHARE BY REVENUES, 2004 ($ MILLIONS)
- Figure 9 SEXUAL DYSFUNCTION PHARMACEUTICAL MANUFACTURER MARKET SHARE BY REVENUES, 2004 (%)
- Table 32 MARKET SIZE OF U.S. SEXUAL DYSFUNCTION DEVICES AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
- Table 33 SEXUAL DYSFUNCTION DEVICES MANUFACTURER MARKET SHARE BY REVENUES, 2004 ($ MILLIONS)
- Figure 10 SEXUAL DYSFUNCTION DEVICES MANUFACTURER MARKET SHARE BY REVENUES, 2004 (%)
  - FUTURE ADVANCEMENTS IN SEXUAL DYSFUNCTION
    - FUTURE ADVANCEMENTS IN(CONTINUED)
- Table 34 SEXUAL DYSFUNCTION DRUGS IN DEVELOPMENT
- Table 34 (CONTINUED)
  - TOTAL MARKET REVENUES AND FORECAST
- Table 35 MARKET SIZE OF U.S. SEXUAL DYSFUNCTION TREATMENTS AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
- Figure 11 MARKET SIZE OF U.S. SEXUAL DYSFUNCTION TREATMENTS AT U.S. MANUFACTURERS SALES LEVELS, 2002-2009 ($ MILLIONS)
PATENTS
- Table 36 SELECTED MANUFACTURER PATENTS FOR REPRODUCTIVE PRODUCTS AND RELATED TECHNOLOGY BY APPLICATION, 1976-PRESENT
  - PATENTS BY APPLICATION
    - INFERTILITY TREATMENTS
    - CONTRACEPTION
    - SEXUAL DYSFUNCTION
  - LEADING MARKET MANUFACTURERS
- Table 37 PATENT ANALYSIS BY SELECTED LEADING REPRODUCTIVE TREATMENT MANUFACTURERS, 1976-PRESENT
TOTAL MARKET
- Table 38 TOTAL REVENUES OF U.S. REPRODUCTIVE TECHNOLOGIES AND PRODUCTS BY CATEGORY AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
- Figure 12 TOTAL REVENUES OF U.S. REPRODUCTIVE TECHNOLOGIES AND PRODUCTS BY CATEGORY AT U.S. MANUFACTURERS SALES LEVELS, 2002-2009 ($ MILLIONS)
- Table 39 TOTAL REVENUES, MARKET SHARE, AND NUMBER OF MANUFACTURERS OF U.S. REPRODUCTIVE TECHNOLOGIES AND PRODUCTS BY MARKET SEGMENT, 2004 ($ MILLIONS)
- Figure 13 NUMBER OF SELECTED MANUFACTURERS BY MARKET SEGMENT, 2004 (%)
- Figure 14 U.S. REPRODUCTIVE TECHNOLOGIES AND PRODUCTS MARKET SHARE BY MARKET SEGMENT, 2004 (%)
  - INDUSTRY PARTICIPANTS BY CATEGORY
- Table 40 REPRODUCTIVE INDUSTRY PARTICIPANTS BY PRODUCT CATEGORY
- Table 40 (CONTINUED)
  - TOTAL MARKET SIZE BY PRODUCT TYPE
- Table 41 TOTAL REVENUES OF U.S. REPRODUCTION PRODUCTS BY TYPE AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
- Figure 15 TOTAL REVENUES OF U.S. REPRODUCTION PRODUCTS BY TYPE AT U.S. MANUFACTURERS SALES LEVELS, 2002-2009 ($ MILLIONS)
APPENDIX
- Table 42 LIST OF COMPANIES
- Table 42 (CONTINUED)
- Table 42 (CONTINUED)
- Table 42 (CONTINUED)
- Table 42 (CONTINUED)
- Table 42 (CONTINUED)
- Table 42 (CONTINUED)
Summary Table:
Table 1 STRUCTURAL HOMOLOGUES OF THE MALE AND FEMALE REPRODUCTIVE SYSTEMS
Table 2 PRESCRIPTION GENERIC DRUG APPROVALS BY COMPANY AND APPROVAL DATE 2003-2004
Table 3 U.S. LIVE BIRTH RATES, 1960-2004 (THOUSANDS)
Table 4 U.S. POPULATION BY SELECTED AGE GROUPS AND BY PERCENT OF TOTAL POPULATION, 2003-2030 (THOUSANDS)
Table 5 CHARACTERISTICS OF WOMEN WHO HAVE HAD A CHILD IN THE LAST YEAR: 2000 AND ESTIMATED 2005
Table 6 WOMEN WHO HAVE HAD A CHILD IN THE LAST YEAR BY AGE AND LABOR FORCE STATUS: 1980 TO 2000
Table 7 ESTIMATED CONTRACEPTIVE USE BY TYPE BY AGE, ETHNIC GROUP AND MARITAL STATUS (%)
Table 8 PRESCRIPTION FERTILITY DRUGS
Table 9 MARKET SIZE OF U.S. INFERTILITY PHARMACEUTICALS AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
Table 10 INFERTILITY PHARMACEUTICAL MANUFACTURER MARKET SHARE BY REVENUES, 2004 ($ MILLIONS)
Table 11 INFERTILITY DRUGS IN DEVELOPMENT
Table 12 2001 NATIONAL SUMMARY OF ARTIFICIAL REPRODUCTIVE THERAPIES
Table 13 2001 NATIONAL ARTIFICIAL REPRODUCTIVE THERAPIES CYCLE PROFILE
Table 14 2001 PREGNANCY SUCCESS RATES
Table 15 MARKET SIZE OF U.S. ARTIFICIAL REPRODUCTIVE TECHNOLOGIES AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
Table 16 MARKET SIZE OF U.S. FERTILITY DIAGNOSTICS AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
Table 17 FERTILITY DIAGNOSTIC MANUFACTURER MARKET SHARE BY REVENUES, 2004 ($ MILLIONS)
Table 18 MARKET SIZE OF U.S. INFERTILITY TREATMENTS AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
Table 19 CONTRACEPTIVE EFFECTIVENESS: THEORETICAL AND ACTUAL USE RATES
Table 20 MOST COMMONLY USED ORAL CONTRACEPTIVES, 2004
Table 21 ESTROGEN AND PROGESTIN HORMONE DOSES IN COMBINED BIRTH CONTROL PILLS
Table 22 PROGESTIN POTENCY OF DIFFERENT ORAL CONTRACEPTIVE PROGESTINS
Table 23 CURRENT PILL PROBLEMS AND CHOICE OF PILL TO SWITCH TO
Table 24 MARKET SIZE OF U.S. CONTRACEPTIVE PHARMACEUTICALS AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
Table 25 CONTRACEPTION PHARMACEUTICAL MANUFACTURER MARKET SHARE BY REVENUES, 2004 ($ Millions)
Table 26 MARKET SIZE OF U.S. CONTRACEPTIVE DEVICES AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
Table 27 CONTRACEPTIVE DEVICE MANUFACTURER MARKET SHARE BY REVENUES, 2004 ($ MILLIONS)
Table 28 CONTRACEPTIVE DRUGS IN DEVELOPMENT
Table 29 MARKET SIZE OF U.S. CONTRACEPTIVE PRODUCTS AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
Table 30 MARKET SIZE OF U.S. SEXUAL DYSFUNCTION PHARMACEUTICALS AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
Table 31 SEXUAL DYSFUNCTION PHARMACEUTICAL MANUFACTURER MARKET SHARE BY REVENUES, 2004 ($ MILLIONS)
Table 32 MARKET SIZE OF U.S. SEXUAL DYSFUNCTION DEVICES AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
Table 33 SEXUAL DYSFUNCTION DEVICES MANUFACTURER MARKET SHARE BY REVENUES, 2004 ($ MILLIONS)
Table 34 SEXUAL DYSFUNCTION DRUGS IN DEVELOPMENT
Table 35 MARKET SIZE OF U.S. SEXUAL DYSFUNCTION TREATMENTS AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
Table 36 SELECTED MANUFACTURER PATENTS FOR REPRODUCTIVE PRODUCTS AND RELATED TECHNOLOGY BY APPLICATION, 1976-PRESENT
Table 37 PATENT ANALYSIS BY SELECTED LEADING REPRODUCTIVE TREATMENT MANUFACTURERS, 1976-PRESENT
Table 38 TOTAL REVENUES OF U.S. REPRODUCTIVE TECHNOLOGIES AND PRODUCTS BY CATEGORY AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
Table 39 TOTAL REVENUES, MARKET SHARE, AND NUMBER OF MANUFACTURERS OF U.S. REPRODUCTIVE TECHNOLOGIES AND PRODUCTS BY MARKET SEGMENT, 2004 ($ MILLIONS)
Table 40 REPRODUCTIVE INDUSTRY PARTICIPANTS BY PRODUCT CATEGORY
Table 41 TOTAL REVENUES OF U.S. REPRODUCTION PRODUCTS BY TYPE AT U.S. MANUFACTURERS SALES LEVELS, THROUGH 2009 ($ MILLIONS)
Table 42 LIST OF COMPANIES
Summary Figure:
Figure 1 U.S. LIVE BIRTH RATES, 1960-2004 (THOUSANDS)
Figure 2 U.S. POPULATION SELECTED AGE GROUPS BY PERCENT OF TOTAL POPULATION, 2003-2030
Figure 3 INFERTILITY PHARMACEUTICAL MANUFACTURER MARKET SHARE BY REVENUES, 2004 (%)
Figure 4 FERTILITY DIAGNOSTIC MANUFACTURER MARKET SHARE BY REVENUES, 2004 (%)
Figure 5 MARKET SIZE OF U.S. INFERTILITY TREATMENTS AT U.S. MANUFACTURERS SALES LEVELS, 2002-2009 ($ MILLIONS)
Figure 6 CONTRACEPTION PHARMACEUTICAL MANUFACTURER MARKET SHARE BY REVENUES, 2004 (%)
Figure 7 CONTRACEPTIVE DEVICE MANUFACTURER MARKET SHARE BY REVENUES, 2004 (%)
Figure 8 MARKET SIZE OF U.S. CONTRACEPTIVE PRODUCTS AT U.S. MANUFACTURERS SALES LEVELS, 2002-2009 ($ MILLIONS)
Figure 9 SEXUAL DYSFUNCTION PHARMACEUTICAL MANUFACTURER MARKET SHARE BY REVENUES, 2004 (%)
Figure 10 SEXUAL DYSFUNCTION DEVICES MANUFACTURER MARKET SHARE BY REVENUES, 2004 (%)
Figure 11 MARKET SIZE OF U.S. SEXUAL DYSFUNCTION TREATMENTS AT U.S. MANUFACTURERS SALES LEVELS, 2002-2009 ($ MILLIONS)
Figure 12 TOTAL REVENUES OF U.S. REPRODUCTIVE TECHNOLOGIES AND PRODUCTS BY CATEGORY AT U.S. MANUFACTURERS SALES LEVELS, 2002-2009 ($ MILLIONS)
Figure 13 NUMBER OF SELECTED MANUFACTURERS BY MARKET SEGMENT, 2004 (%)
Figure 14 U.S. REPRODUCTIVE TECHNOLOGIES AND PRODUCTS MARKET SHARE BY MARKET SEGMENT, 2004 (%)
Figure 15 TOTAL REVENUES OF U.S. REPRODUCTION PRODUCTS BY TYPE AT U.S. MANUFACTURERS SALES LEVELS, 2002-2009 ($ MILLIONS)

簡介
目錄
相關商品

使用指南產品及服務須知網站導覽

星期一到星期五 / 9:30am - 6:00pm
TEL: 02-2729-4219 (+886-2-2729-4219)
E-mail: tw-info@gii.co.jp

人類生殖技術(Human Reproductive Technologies)：製品、市場、參與企業 -2005年版-

Human Reproductive Technologies: Products, Markets and Manufacturers

簡介

說明